Bruker Corporation (BRKR)
40.16
1.40 (3.61%)
At close: Apr 14, 2025, 3:46 PM
3.61% (1D)
| Bid | 40.02 |
| Market Cap | 6.09B |
| Revenue (ttm) | 3.37B |
| Net Income (ttm) | 113.1M |
| EPS (ttm) | 0.76 |
| PE Ratio (ttm) | 52.84 |
| Forward PE | 20.73 |
| Analyst | Hold |
| Ask | 40.28 |
| Volume | 2,188,073 |
| Avg. Volume (20D) | 2,098,218 |
| Open | 39.61 |
| Previous Close | 38.76 |
| Day's Range | 38.97 - 40.35 |
| 52-Week Range | 34.10 - 88.51 |
| Beta | 1.18 |
About BRKR
Bruker Corporation develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States and internationally. The company operates through three segments: Bruker Scientific Instruments (BSI) Life Science, BSI NANO, and Bruker Energy & Supercon Technologies. It offers life science tools, and single and multiple modality systems; life science mass spectrometry; MALDI Biotyper rapid pathogen ide...
Industry Medical - Devices
Sector Healthcare
IPO Date Aug 4, 2000
Employees 11,396
Stock Exchange NASDAQ
Ticker Symbol BRKR
Website https://www.bruker.com
Analyst Forecast
According to 10 analyst ratings, the average rating for BRKR stock is "Hold." The 12-month stock price forecast is $63, which is an increase of 56.87% from the latest price.
Stock ForecastsNext Earnings Release
Bruker Corporation is scheduled to release its earnings on May 7, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
3 days ago
+1.81%
Bruker shares are trading higher after the company...
Unlock content with
Pro Subscription
2 months ago
-8.02%
Bruker shares are trading lower after Barclays cut its price target on the stock from $69 to $65.
